Beta-cell rest: A strategy for the prevention of autoimmune diabetes

Autoimmunity

Volumn 26, Issue 2, 1997, Pages 117-122

  Karlsson, F Anders ^a   Björk, Elisabeth ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoantigen; Diabetes; Diazoxide; Human; Type 1

Indexed keywords

AUTOANTIGEN;

AUTOIMMUNITY; DIABETES MELLITUS; IMMUNOSUPPRESSIVE TREATMENT; PANCREAS ISLET BETA CELL; REVIEW;

EID: 0030722646     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939709003855     Document Type: Review

References (67)

1. Czarnocka, B., Ruf, J., Ferrand, M., Carayon, P., Lissitzy, S. (1985). Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Letters. 190, 147-51.
2. Seto, P., Hirayu, H., Magnusson, R., Gestautas, J., Portmann, L., DeGroot, L. J., et al. (1987). Isolation of a complementary DNA clone for thyroid microsomal antigen. Homology with the gene for thyroid peroxidase. J Clin Invest, 80 1205-8.
3. Karlsson, F. A., Burman, P., Lööf, L., Mårdh, S. (1988). The major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid producing H,K-ATPase of the stomach. J Clin Invest, 81, 475-9.
4. +-ATPase (proton pump). Proc Natl Acad Sci USA, 87, 6418-22.
5. Baekkeskov, S., Jan-Aanstoot, H., Christgau, S., et al. (1990). Identification of the 64 K antigen in insulin-dependent diabetes as the GABA-synthesizing enzyme enzyme glutamatic acid decarboxylase. Nature, 347, 151-6.
6. Rabin, D. U., Pleasic, S. M., Shapiro, J. A., Yoo-Warren, H., Oles, J., Hicks, J. M., et al. (1994). Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol, 152, 3183-8.
7. Winqvist, O., Karlsson, F. A., Kämpe, O. (1992). 21-hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet, 339, 1559-62.
8. Bednarek, J., Furmaniak, J., Wedlock, N. et al. (1992). Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS Letters, 39, 51-5.
9. Winqvist, O., Gustafsson, J., Rorsman, F., Karlsson, F. A., Kämpe, O. (1993). Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest, 92, 2377-85.
10. Arif, S., Vallian, S., Farzaneh, F., Zanone, M. M., James, S. L., Pietropaolo, M. et al. (1996). Identification of 3β-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease. J Clin Endocrinol Metab, 81, 4439-45.
11. Roitt, I. M., Doniach, D., Campbell, P. N., Vaughan Hudson, R. (1956). Autoantibodies in Hashimoto's disease (lymphadenoid goitre). Lancet, ii, 820-1.
12. Schwartz, M. (1958). Intrinsic-factor-inhibiting substance in serum of orally treated patients with pernicious anemia. Lancet, ii, 61-2.
13. Pav, J., Prague, M. D., Jexokova, Z., Skrha, F. (1963). Insulin antibodies. Lancet, ii, 221-2.
14. Palmer, J. P., Asplin, C. M., Clemons, P. (1983). Insulin autoantibodies in insulin-dependent diabetes before insulin treatment. Science, 222, 1337-9.
15. Kohno, Y., Hiyama, Y., Shimojo, N., Niimi, H., Nakajima, H., Hosoya, T. (1986). Autoantibodies to thyroid peroxidase in patients with chronic thyroiditis: effect of antibody binding on enzyme activities. Clin Exp Immunol, 65, 534-41.
16. +-adenosine triphosphatase, the proton pump of the stomach. Gastroenterology, 96, 1434-8.
17. Björk, E., Velloso, L. A., Kämpe, O., Karlsson, F. A. (1994). GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes, 43, 161-5.
18. Furmaniak, J., Kominami, S., Asawa, T., Wedlock, N., Colls, J., Smith, B. R. (1994). Autoimmune Addison's disease-evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency. J Clin Endocrinol Metab, 79, 1517-21.
19. Weetman, A. P., McGregor, A. M. (1994). Autoimmune thyroid disease: further developments in our understanding. Endocr Rev, 15, 788-830.
20. Amino, N., Mori, H., Iwatani, Y. et al. (1982). High prevalance of transient postpartum thyrotoxicosis and hypothyroidism. N Engl J Med, 306, 849-52.
21. Jansson, R., Dahlberg, P. A., Karlsson, F. A. (1988). Postpartum thyroiditis. Ballieres Clin Endocrinol Metab, 2, 619-35.
22. Burman, P., Kämpe, O., Kraaz, W., Lööf, L., Smolka, A., Karlsson, F. A., et al. (1992). A study of autoimmune gastritis in the postpartum period and at a 5 year follow up. Gastroenterology, 103, 934-42.
23. Takasu, N., Komiya, I., Nagasawa, Y., Asawa, T., Yamada, T. (1990). Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing's syndrome due to an adrenocortical adenoma. N Engl J Med, 322 1708-12.
24. Burman, P., Töttermann, T. H., Öberg, K., Karlsson, F. A. (1986). Thyroid autoimmunity in patients on long term therapy with leukocyte derived interferon. J Clin Endocrinol Metab, 63, 1086-90.
25. Gisslinger, H., Gilly, B., Woloszczuk, W., Mayr, W. R., Havelec, L., Linkesch, W., et al. (1992). Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol, 90, 363-7.
26. Atkins, M. B., Mier, J. W., Parkinson, D. R., Gould, J. A., Berkman, E. M., Kaplan, M. M. (1998). Hypothyroidism after treatment with interleukin-2 and lymphokine activated killer cells. N Engl J Med, 318, 1557-63.
27. Hall, R., Lazarus, J. H. (1987). Changing iodine intake and the effect on thyroid disease. Br Med J, 294, 721-2.
28. Jansson, R., Karlsson, F. A., Dahlberg, P. A. (1985). Thyroxine, methimazole and thyroid microsomal autoantibody titres in hypothyroid Hashimoto's thyroiditis. Br Med J, 290, 11-2.
29. Chiovato, L., Marcocci, C., Mariotti, S., Mori, A., Pinchera, A. (1986). L-thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic myxedema and in hypothyroid, but not in euthyroid Hashimoto's disease. J Endocrinol Invest, 9, 299-305.
30. De Bellis, A., Bizzaro, A., Rossi, R., Paglionico, A., Criscuolo, T., Lombardi, G., et al. (1993). Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies. J Clin Endocrinol Metab, 76, 1002-7.
31. Botazzo, G. F. (1986). Type 1 diabetes mellitus: a chronic autoimmune disease. N Engl J Med, 314, 1360-8.
32. Gorsuch, A. N., Spencer, K. M., Lister, J., McNally, J. M., Dean, B. M., Bottazzo, G. F. (1981). Evidence for a long prediabetic period in type 1 (insulin dependent) diabetes mellitus. Lancet, ii, 1363-4.
33. Leslie, R. D. G., Pyke, D. A. (1991). Escaping insulin dependent diabetes. Characteristic immunological changes don't invariably lead to disease. Br Med J, 312, 1103-4.
34. Buschard, K., Buch, I., Molsted-Pedersen, L., Hougard, P., Kuhl, C. (1987). Increased incidence of true type 1 diabetes during pregnancy. Br Med J, 294, 275-9.
35. Nishizuka, Y. (1982). A novel experimental system of organ-localized autoimmune diseases in the mouse. Acta Pathol Jpn, 32, Suppl 1, 211-22.
36. Reinhart, W., Paul, T. L., Allen, E. M., Alex, S., Yang, Y-N., Appel, M. C., et al. (1988). Effect of L-thyroxine administration on the incidence of iodine induced and spontaneous lymphocytic thyroiditis. Endocrinotogy, 122, 1179-81.
37. Gotfredsen, C. F., Buschard, K., Frandsen, E. K. (1985). Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia, 28, 933-5.
38. Appel, M. C., O'Neil, J. J. (1986). Prevention of spontaneous diabetes in the BB rat by insulin treatment. Pancreas, 1, 356.
39. Atkinson, M. A., MacLaren, N. K., Luchetta, R. (1990). Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes, 39, 933-7.
40. Hernandez, A., Zorrilla, E., Gershberg, H. (1968). Serum-insulin in remission of juvenile diabetes. Lancet, ii, 223.
41. Weber, B. (1972). Glucose-stimulated insulin secretion during 'remission' of juvenile diabetes. Diabetologia, 8, 189-95.
42. Leahy, J. L., Bonner-Weir, S., Weir, G. C. (1988). Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest, 81, 1407-14.
43. Rossetti, L., Giaccari, A., DeFronzo, R. (1990). Glucose toxicity. Diabetes Care, 13, 610-30.
44. Eizirik, D. L., Sandler, S., Palmer, J. P. (1993). Repair of pancreatic beta-cells. A relevant phenomenon in early IDDM? Diabetes, 42, 1383-91.
45. Yki-Järvinen, H., Koivisto, V. A. (1986). Natural course of insulin resistance in type 1 diabetes. N Engl J Med, 315, 225-9.
46. Madsbad, S., Krarup, T., Reguer, L., Faber, O. K., Binder, C. (1981). Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics. Diabetologia, 20, 530-4.
47. Perlman, K., Ehrlich, R. M., Filler, R. M., Albisser, A. M. (1984). Sustained normoglycemia in newly diagnosed type 1 diabetic subjects. Diabetes. 33, 995-1001.
48. Shah, S. C., Malone, J. I., Simpson, N. E. (1989). A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med, 320, 550-4.
49. Ludvigsson, J., Heding, L., Larsson, Y., Leander, E. (1977). C-peptide in juvenile diabetics beyond the postinitial remission period. Acta Paediatr Scand, 66, 177-84.
50. Steffes, M., Tamborlane, W., Becker, D., Palmer, J., Cleary, P., for the DDCT Research Group, Bethseda, M. D. (1996). The effect of intensive diabetes treatment on residual b-cell function in the diabetes and complications trial (DCCT). Diabetes, 45, Suppl 2, Abstr. 59.
51. Kämpe, O., Andersson, A., Björk, E., Hallberg, A., Karlsson, F. A. (1989). High-glucose stimulation of 64,000 Mr islet cell autoantigen expression. Diabetes, 38, 1326-8.
52. Björk, E., Kämpe, O., Karlsson, F.A., Pipeleers, D. G., Andersson, A., Hellerström, C., Eizirk, D. L. (1992). Glucose regulation of the autoantigen GAD65 in human pancreatic islets. J Clin Endocrinol Metab, 75, 1574-6.
53. Björk, E., Kämpe, O., Gravé, J., Hallberg, A., Norheim, I., Karlsson, F. A. (1993). Modulation of beta-cell activity and its influence on islet cell antibody (ICA) and islet cell surface antibody (ICSA) reactivity. Autoimmunity, 16, 181-8.
54. Hagopian, W. A., Karlsen, A. E., Petersen, J. S., Teague, J., Gervassi, A., Jiang, J., Fujimoto, W., Lernmark, A. (1993). Regulation of glutamic acid decarboxylase diabetes autoantigen expression in highly purified isolated islets from Macaca nemestrina. Endocrinology, 132, 2674-81.
55. McCulloch, D. K., Barmeier, H., Neifing, J. L., Palmer, J. P. (1991). Metabolic state of the pancreas affects end-point titre in the islet cell antibody assay. Diabetologia, 34, 622-5.
56. Björk, E., Kämpe, O., Andersson, A., Karlsson, F. A. (1992). Expression of the 64 kDa/GAD rat islet cell autoantigen is influenced by the rate of insulin secretion. Diabetologia, 32, 490-3.
57. Aguilar-Bryan, L, Nichols, C. G., Wechsler, S. W., Clement, J. P. IV., Boyd, A. E. III., Gonzalez, G., Herrera-Sosa, H., Nguy, K., Bryan, J., Nelson, D. A. (1995). Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science, 268, 423-6.
58. Inagaki, N., Gonoi, T., Clement, J. P. IV., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., Bryan, J. (1995). Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science, 270, 1166-70.
59. Sturgess, N. C., Ashford, M. L., Cook, D. L., Hales, C. N. (1985). The sulphonylurea receptor may be an ATP-senitive potassium channel. Lancet, ii, 474-5.
60. + channel in mouse pancreatic beta-cells. Pflugers Archiv, 407, 493-9.
61. Goode, P. N., Farndon, J. R., Anderson, J., Johnston, I. D., Morte, J. A. (1986). Diazoxide in the management of patients with insulinoma. World J Surg, 10, 586-92.
62. Keller, R. J., Eisenbarth, G. S., Jackson, R. A. (1993). Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet, 341, 927-8.
63. Zhang, Z. J., Davidson, L., Eisenbarth, G., Weiner, H. L. (1991). Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA, 88, 10252-6.
64. Björk, E., Berne, C., Kämpe, O., Wibell, L., Oskarsson, P., Karlsson, F. A. (1996). Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes. Diabetes, 45, 1427-30.
65. Fukuda, M., Tanaka, A., Tahara, Y., Ikegami, H., Yamamoto, Y., Kumahara, Y., Sima, K. (1988). Correlation between minimal secretory capacity of pancreatic β-cells and stability of diabetic control. Diabetes, 37, 81-8.
66. Sjöberg, S., Gunnarsson, R., Gjötterberg, M., Lefvert, A. K., Persson, A., Ostma, J. (1987). Residual insulin production, glycemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 30, 208-13.
67. Nakanishi, K., Kobayashi, T., Inoko, H., Tsuji, K., Murase, T., Kosaka, K. (1995). Residual b-cell function and HLA-A24 in IDDM. Markers of glycemic control and subsequent development of diabetic retinopathy. Diabetes, 44, 1334-9.